SCYNEXIS Inc
F:135A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SCYNEXIS Inc
F:135A
|
US |
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
XBER:RER1
|
IT |
|
E
|
Exor NV
XMUN:EYX
|
NL |
|
Publicis Groupe SA
F:PU41
|
FR |
|
H
|
Haier Smart Home Co Ltd
DUS:690D
|
CN |
|
Assystem SA
PAR:ASY
|
FR |
|
T
|
TAG Immobilien AG
DUS:TEG
|
DE |
|
Aena SME SA
F:A440
|
ES |
|
B
|
Basf Se
SWB:BASA
|
DE |
|
N
|
Naturgy Energy Group SA
DUS:GAN
|
ES |
|
A
|
AXA SA
SWB:AXA
|
FR |
|
H
|
Haier Smart Home Co Ltd
OTC:HRSHF
|
CN |
|
Nurexone Biologic Inc
F:J90
|
CA |
|
Guardant Health Inc
NASDAQ:GH
|
US |
|
P
|
Parker-Hannifin Corp
F:PAR
|
US |
Wall St Price Targets
135A Price Targets Summary
SCYNEXIS Inc
According to Wall Street analysts, the average 1-year price target for
135A is 4.71 EUR with a low forecast of 3.33 EUR and a high forecast of 6.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 135A's stock price target?
Price Target
4.71
EUR
According to Wall Street analysts, the average 1-year price target for
135A is 4.71 EUR with a low forecast of 3.33 EUR and a high forecast of 6.45 EUR.
What is the Revenue forecast for SCYNEXIS Inc?
Projected CAGR
-11%
Over the last 12 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is -11%.